PBLS
PBLS
US6989551014
Parabilis Medicines, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
152.079.000 126.125.000
20.6%
Operating Income -152.079.000 -126.125.000
20.6%
Pretax Income -145.889.000 -117.914.000
23.7%
Net Income Common Stockholders -186.933.000 -161.481.000
15.8%
-- --
--
-- --
--
ende